For children with the eye cancer retinoblastoma, researchers are studying a CAR T-cell therapy in which the engineered immune cells are packaged in a biodegradable material called a hydrogel and then injected directly into tumors.
from Cancer Currents: An NCI Cancer Research Blog https://ift.tt/38sgZ8X
from Cancer Currents: An NCI Cancer Research Blog https://ift.tt/38sgZ8X